文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Dorota Knut-Bojanovska
发表
Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial.
P. Sonneveld, A. Waage, N. Abildgaard, 2018, Haematologica.